Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
5(42%)
Results Posted
33%(2 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
11
92%
Ph phase_1
1
8%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

5

trials recruiting

Total Trials

12

all time

Status Distribution
Active(5)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Recruiting5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
5
Success Rate
85.7%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (8.3%)
N/A11 (91.7%)

Trials by Status

completed650%
terminated18%
recruiting542%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
12